Barclays PLC (BCY)
XETRA Stock Exchange · Germany · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 4.886 |
|---|---|
| 52-week range | 4.205 – 6.296 |
| Return, 1 month / 3 months | −10.0% / −20.1% |
| Return, 1 year / 3 years | +13.5% / +219.5% |
| Trend | Below its 200-day average |
| RSI (14) | 29 |
| Volatility (1 year) | 29.5% |
| Worst drawdown (1 year) | -24.7% |
| Average daily value traded | 0.51M EUR |
| Dividend yield | 3.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Barclays PLC is a British bank based in London. It serves retail customers through high street branches and digital channels, offering current accounts, savings, mortgages, loans and credit cards. Its international operations provide investment banking, corporate lending, wealth management and payments services to companies, institutions and governments around the world. The group also runs a cards and consumer lending business, and it operates across Europe, the Americas, Africa and Asia alongside its home market in the United Kingdom.
Barclays PLC trades under the code BCY on the XETRA Stock Exchange in Germany, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Barclays PLC (BCY) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 4.886 on 22 October 2026.
Its price-based Market X-Ray is 56 out of 100 (a fair price profile), ranking 314 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 13.5% and over the last three months it fell 20.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 48 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -8.6% | ||
| From 52-week high | -21.3% | ||
| Momentum | 47 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -20.1% | ||
| 6-month return | -1.1% | ||
| 12-month return, skipping the last month | 26.1% | ||
| Stability (higher is calmer) | 67 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 29.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -24.7% | ||
| Liquidity | 66 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.51M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 57 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.3% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −4.5% |
|---|---|
| 1 month | −10.0% |
| 3 months | −20.1% |
| 6 months | −1.1% |
| 1 year | +13.5% |
| 3 years | +219.5% |
| 5 years | +144.6% |
Signals
| 50-day / 200-day average | 5.483 / 5.347 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.122 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 6 Aug 2026 | GBP 0.0699 |
| 19 Feb 2026 | GBP 0.0664 |
| 7 Aug 2025 | GBP 0.0356 |
| 27 Feb 2025 | GBP 0.0652 |
| 15 Aug 2024 | GBP 0.0344 |
| 29 Feb 2024 | GBP 0.0628 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.